Generative artificial intelligence (GenAI) will save clinicians up to 10% of their time and is expected to save $100 billion in annual healthcare costs in Asia Pacific (excluding Japan) by 2025, enabling more workflow automation and efficiency .

An IDC report shows that by the end of 2027, 60% of Asia Pacific healthcare organizations will double their investments in GenAI, driven by the need to expand hyper-personalized patient experiences, improve collaboration, and promote equity.

GenAI is becoming a transformative force in healthcare and will impact workforce efficiency and hyper-personalization in the care process.

“With the emergence of GenAI and the demand for consumerization of healthcare, the next five years will be a defining period for the healthcare industry, and we are currently at the beginning of this exciting journey,” said Manoj Vallikkat, senior researcher. IDC Asia Pacific Healthcare Insights Manager.

Adoption of AI solutions by care providers in Asia Pacific will increase by 60% by 2026, driven by the need to improve diagnostic accuracy, speed and workflow efficiency.

The report states that by 2027, 50% of the healthcare industry in Asia Pacific will leverage GenAI to address data and workflow fragmentation in care environments to improve diagnosis and patient safety, thereby scaling care everywhere.

Doubling the number of home hospital patients will drive a 55% increase in investment in technology-enabled integrated care programs by 2026 to address patient safety, workforce and care access issues in Asia Pacific.

“In healthcare, the unique risks associated with AI are significant, which requires a greater focus on explainability and data security,” Vallikkat added.